Ablynx Receives Milestone Payment as Collaborator Receives IND Approval for a Nanobody in Oncology

News   Apr 06, 2012

 
Ablynx Receives Milestone Payment as Collaborator Receives IND Approval for a Nanobody in Oncology
 
 
 

RELATED ARTICLES

Biomedical Catalyst Award Goes To BioMoti, Pharmidex and Queen Mary University of London

News

The grant was awarded under the Biomedical Catalyst funding competition to support preclinical studies of new therapeutic approaches for hard-to-treat tumours including advanced ovarian, triple negative breast and pancreatic cancers.

READ MORE

A New Tactic in the Fight Against Drug-Resistant Infections

News

$1 million research grant could lead to life-saving antibiotics.

READ MORE

Will we be able to use zinc oxide nanoparticles as fertilizers?

News

Nanoparticle fertilisers do not pose a toxicity risk for food crops.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Applied Sciences

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE